Explore

Trendline Trendline
NeuLogiq Platform Validates Safety of New Depression Treatment in Phase 1b Study

NeuLogiq Platform Validates Safety of New Depression Treatment in Phase 1b Study

NeuLogiq Platform Validates Safety of New Depression Treatment in Phase 1b Study
Trendline Trendline
Bristol Myers Squibb's Phase 3 Celmod Trial Shows Promising Results for Multiple Myeloma Patients

Bristol Myers Squibb's Phase 3 Celmod Trial Shows Promising Results for Multiple Myeloma Patients

Bristol Myers Squibb's Phase 3 Celmod Trial Shows Promising Results for Multiple Myeloma Patients
Trendline Trendline
Avenzo Therapeutics Begins Dosing in New Breast Cancer Treatment Study

Avenzo Therapeutics Begins Dosing in New Breast Cancer Treatment Study

Avenzo Therapeutics Begins Dosing in New Breast Cancer Treatment Study
Trendline Trendline
Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer

Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer

Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer
Trendline Trendline
Parexel to Showcase Oncology Research and Launch Patient-Centric Campaign at ASCO 2026

Parexel to Showcase Oncology Research and Launch Patient-Centric Campaign at ASCO 2026

Parexel to Showcase Oncology Research and Launch Patient-Centric Campaign at ASCO 2026
Trendline Trendline
GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B
Trendline Trendline
Bristol Myers Squibb's Mezigdomide Shows Significant Efficacy in Multiple Myeloma Treatment

Bristol Myers Squibb's Mezigdomide Shows Significant Efficacy in Multiple Myeloma Treatment

Bristol Myers Squibb's Mezigdomide Shows Significant Efficacy in Multiple Myeloma Treatment
Trendline Trendline
Acurex Biosciences Secures ASAP Grant to Innovate Parkinson's Disease Treatment

Acurex Biosciences Secures ASAP Grant to Innovate Parkinson's Disease Treatment

Acurex Biosciences Secures ASAP Grant to Innovate Parkinson's Disease Treatment
Trendline Trendline
Newron Pharmaceuticals to Engage Investors at June 2026 Conferences in New York and Virtually

Newron Pharmaceuticals to Engage Investors at June 2026 Conferences in New York and Virtually

Newron Pharmaceuticals to Engage Investors at June 2026 Conferences in New York and Virtually
Trendline Trendline
Alkermes to Present New Data on Psychiatric Treatments at ASCP Annual Meeting

Alkermes to Present New Data on Psychiatric Treatments at ASCP Annual Meeting

Alkermes to Present New Data on Psychiatric Treatments at ASCP Annual Meeting
Trendline Trendline
InduPro Therapeutics Names Amanda J. Redig as Chief Medical Officer to Advance Cancer Therapies

InduPro Therapeutics Names Amanda J. Redig as Chief Medical Officer to Advance Cancer Therapies

InduPro Therapeutics Names Amanda J. Redig as Chief Medical Officer to Advance Cancer Therapies
Trendline Trendline
Oligonucleotide Manufacturers Shift to Cost-Effective High Production Methods Amid Rising Demand

Oligonucleotide Manufacturers Shift to Cost-Effective High Production Methods Amid Rising Demand

Oligonucleotide Manufacturers Shift to Cost-Effective High Production Methods Amid Rising Demand